問題詳情

60.有關肥胖控制用藥之敘述,下列何者正確?
(A)orlistat作用機轉為促進腸胃道lipase之活性
(B)phentermine常見之副作用為失眠
(C)liraglutide可協助懷孕婦女控制體重
(D)lorcaserin為dopamine receptor agonist

參考答案

答案:B
難度:簡單0.667
書單:沒有書單,新增

用户評論

terminator812】評論

A:要改成抑制C:孕婦用藥等級:C。若妳已懷孕,就診時請務必告知醫師並告知週數D:5-HT2c受體致效劑

】評論

A. Orlistat(Xenical*): lipase inhibitor,抑制gastric, pancreatic lipase,降低飲食中30%脂肪吸收→副作用:腹痛、油便、脂肪瀉C. Liraglutide(Saxenda*;Victoza*): 禁用於懷孕婦女的減重,整體來說懷孕期期間的適度增重對胎兒傾向較好的結果,不建議liraglutide用在此目的(沒有潛在的好處,加上可能傷害胎兒)However, moderate gestational weight gain based on pre-pregnancy BMI is required for positive fetal outcomes in all pregnancies, including patients who are overweight or obese. D. Lorcaserin(Belviq*): 5-HT2C agonist,2020因增加致癌風險TFDA已要求全面下市回收(出題老師不要再考它了!!它在減肥藥物中已經退伍了)ref: UpToDate